Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
BioVaxys Enters Major Bioproduction Agreement With Wuxi Biologics (Hong Kong) Ltd. To Synthesize Proteins For Its SARS-CoV-2 Vaccine And COVID-T™ Immunodiagnostic Programs 2021-03-15 20:00
BioVaxys Expanding Technology Platform To Address Emerging SARS-CoV-2 Variants 2021-03-01 21:00
BioVaxys Announces Appointment To Its Scientific Advisory Board 2021-02-22 21:00
BioVaxys and BioElpida Sign Term Sheet for Clinical Grade BVX-0918A Bio-production 2021-02-18 21:00
BioVaxys and Procare Health Announce Broad Co-Development, Joint Commercialization and Marketing Collaboration for Cancer and Viral Vaccines 2021-02-10 21:26
Covid-T™ Clinical Development Program Initiated Regulatory Advisory Group Engaged 2021-01-28 21:46
BioVaxys Announces Initiation Of Cancer Vaccine EU Clinical Program, Completion Of BVX-0320 Preclinical Program 2021-01-25 21:00
BioVaxys Vaccine Platform Stimulates Robust T-cell Response Against Viral Antigens 2020-12-21 21:00
1 2